Navigation Links
Vion Pharmaceuticals Announces Presentation of Data from Phase III Trial of Cloretazine(R) (VNP40101M) and Cytarabine in Relapsed Acute Myelogenous Leukemia at the ASCO(R) Annual Meeting
Date:6/2/2008

e(R) (VNP40101M) treatment arm versus 9% for the control arm. Sepsis, pneumonia and infection accounted for 67% of the deaths on the treatment arm.

The most common severe adverse events (Grade 3 through 5) in both arms were hematologic, infectious, and respiratory disorders. The duration of myelosuppression, as well as the incidence of infectious and respiratory adverse events, was higher in the treatment arm as compared to the control arm.

Alan Kessman, Chief Executive Officer, said, "Although this trial was discontinued for safety reasons due to a disparity in on-study mortality between the two arms, in light of the objective response rate of the cytarabine and Cloretazine(R) (VNP40101M) arm, we believe that this combination merits further evaluation in first relapse of AML with modifications to address the observed toxicity and mortality at the studied dose and schedule."

At ASCO(R), data were presented on the first 206 patients treated on the trial. The median age was 59 years and the median duration of patients' first remission was 9.7 months. 139 patients and 67 patients were treated on the treatment arm and the control arm respectively. The demographics of the patients in the treatment arm were essentially similar to patients in the control arm across age, sex, and ECOG performance status.

Mr. Kessman added, "Now that the clinical hold has been lifted by the FDA, we have the opportunity to move forward in first relapse of AML with a revised protocol of this combination. However, our main focus at the present time continues to be on achieving registration for Cloretazine(R) (VNP40101M) in the United States in previously untreated elderly patients with de novo poor-risk AML."

The Phase III trial was a double-blind placebo-controlled randomized evaluation of a treatment arm consisting of cytarabine plus Cloretazine(R) (VNP40101M) versus a control arm regimen of cytarabine and placebo. The trial was designed to accrue patients i
'/>"/>

SOURCE Vion Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
2. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
3. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
4. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
5. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
6. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
8. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
9. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
10. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
11. Class Settlement Could Result in Considerable Savings for Certain Consumers of Prescription Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... ... September 01, 2015 , ... ... now offering the MonaLisa Touch® , an innovative vaginal health laser procedure ... is a new hormone-free treatment for atrophic vaginitis, a condition that causes vaginal ...
(Date:9/1/2015)... ... September 01, 2015 , ... The ... Information Management has been granted continued accreditation based on a successfully completed ... “Achieving and maintaining this accreditation takes the involvement and dedication of each ...
(Date:9/1/2015)... ... 01, 2015 , ... PetPace, the provider of an innovative ... activity, today announced its integration with leading veterinary Practice Management Software vendor Cornerstone. ... Practice Management Software packages in the US. Practice Management Software helps veterinarians manage ...
(Date:9/1/2015)... ... September 01, 2015 , ... Discovia, a ... announced today that it has hired Scott Sanderson, an experienced business development professional ... Sanderson will be responsible for establishing and managing new client relationships in the ...
(Date:9/1/2015)... ... ... Royal River Natural Foods, a locally-owned independent natural health store in Freeport, Maine, ... found that, among those who had a stroke, people who used multivitamins survived longer ... September 2015 issue of “Natural Insights for Well Being,” which Royal River Natural Foods ...
Breaking Medicine News(10 mins):Health News:Houston's Plaza OB/GYN Now Offering the MonaLisa Touch® 2Health News:Houston's Plaza OB/GYN Now Offering the MonaLisa Touch® 3Health News:Edge Information Management Granted Continued NAPBS Accreditation 2Health News:Edge Information Management Granted Continued NAPBS Accreditation 3Health News:Petpace-Cornerstone Integration Lowers Overhead, Raises Data Visibility for Veterinary Practices 2Health News:Former NFL Standout Scott Sanderson Joins eDiscovery Leader Discovia 2Health News:New Study Finds Multivitamins Extend Life After Stroke, Retailer Reports 2
... public about an earlier warning by the UK Food Standards ... to contain unhealthy levels of a toxic// substance called 3-monochloropropan-1,2-diol ... soy sauce was found to be above the prescribed EU ... the soy sauce due to 3-MCPD, points to the cooking ...
... About half of Australians with arms in plaster casts are ... their risk of crashing, according to recent research.// ... a plaster cast neither in Australia nor in New Zealand, ... they have an accident in either country. , ...
... for the tribal elders to impose a smoking ban on marae, ... leaders.// ,Te Tai Tokerau MP Hone Harawira has advocated ... at the unreasonably high Maori smoking rates. It has been reported ... rates among the women being one of the highest in the ...
... Tamil Nadu, leading a pilot project in sterilisation of street ... animal birth control (ABC) initiative across the country.// ,As ... states have decided to implement a programme that was successfully ... annual killing of 20,000 street dogs. ,It ...
... hands to promote healthcare in the two countries and this ... the Chinese Embassy said here Saturday.// ,"Healthcare is an ... countries must join hands in this field. A doctors' exchange ... said Cao Jiangru, first secretary, science and technology of the ...
... St. John’s wort (hypericum perforatum) is one of the five ... many to treat the symptoms of depression, and many prefer ... the herb has been the subject of growing concern about ... and cyclosporin, a medication used with those who have received ...
Cached Medicine News:Health News:Mixed response Evoked Among The Tribal Elders For The Call On Smoking Ban 2Health News:India and China Agrees to Promote Healthcare Jointly 2Health News:St. John's Wort in Pregnancy and Lactation 2
(Date:9/1/2015)... 1, 2015 Agena Bioscience TM today announced ... , a commercial and financial hub from which many biotech ... testing laboratories in mainland China . ... Bioscience,s global sales with almost sixty MassARRAY ® Systems ... will allow us to expand our reach and foster ...
(Date:9/1/2015)... TAIPEI , Sept. 1, 2015 ... 2,500 employees, SHL Group has rapidly reached 3,000 ... yet rapid growth in the injectable drug delivery ... A global leader in the design ... SHL offers innovative designs, robust manufacturing capabilities, a ...
(Date:9/1/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/rd9jbr/introduction_to ... "Introduction to Veterinary Pharmacovigilance (London, UK - September ... This course has been designed to provide ... concerned with Veterinary Pharmacovigilance. New entrants, support staff ... better understanding of veterinay drug safety will benefit ...
Breaking Medicine Technology:Agena Bioscience Opens Office in Shanghai, China 2SHL Group Reaches Major Milestone of 3000 Employees 2Introduction to Veterinary Pharmacovigilance Seminar (London, UK - September 23-24) 2
Smith & Nephew ACUFEX scissors are constructed without pins for maximum strength, dependability, durability, and safety.,A wide range of tips and angles enable the surgeon to effectively dissect any ...
These backbiters enable simple access to the anterior horn of the meniscus....
The narrow shaft and compact jaw design facilitates access and use in tight spaces, particularly useful in the posterior aspect of the knee....
... Arthrotek® Precision Hand Instruments were developed in ... feel, while still having an instrument with ... without the fear of the bending or ... and manufactured to conform to the surgeon's ...
Medicine Products: